Increased matrix-metalloproteinase-2 and matrix-metalloproteinase-9 expression in the brain of dystrophic mdx mouse

Neuroscience

Volumn 140, Issue 3, 2006, Pages 835-848

  Nico, B ^a   Corsi, P ^a   Ria, R ^a   Crivellato, E ^b   Vacca, A ^a   Roccaro, A M ^a   Mangieri, D ^a   Ribatti, D ^a   Roncali, L ^a  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

Author keywords

blood brain barrier; Duchenne muscular dystrophy; matrix metalloproteinase; vascular endothelial growth factor

Indexed keywords

CD3 ANTIBODY; CD31 ANTIGEN; ENDOTHELIAL CELL GROWTH FACTOR; GELATINASE A; GELATINASE B; GLIAL FIBRILLARY ACIDIC PROTEIN; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CELL ULTRASTRUCTURE; CHOROID PLEXUS; CONFOCAL LASER MICROSCOPY; DYSTROPHY; ELECTRON MICROSCOPY; ENDOTHELIUM CELL; ENZYME SYNTHESIS; FEMALE; GLIA CELL; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICROVILLUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIGENS, CD31; ASTROCYTES; BLOOD-BRAIN BARRIER; BRAIN; CHOROID PLEXUS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; EPENDYMA; FEMALE; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MICROCIRCULATION; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVILLI; MUSCULAR DYSTROPHY, DUCHENNE; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33646862798     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.02.077     Document Type: Article

References (49)

1. Albini A., Iwamoto Y., Kleinman H.K., Martin G.R., Aaranson S.A., Kozlowski J.M., and McEwan R.N. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47 (1987) 3239
2. Anthony D.C., Ferguson B., Matyzak M.K., Miller K.M., Esiri M.M., and Perry V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol 23 (1997) 406-415
3. Asahi M., Wang X., Mori T., Sumii T., Jung J.C., Moskowitz M.A., Fini M.E., and Lo E.H. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21 (2001) 7724-7732
4. Breier G., Albrecht U., Sterrer S., and Risau W. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114 (1992) 521-532
5. Breier G., Clauss M., and Risau W. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Dev Dyn 204 (1995) 228-239
6. Bulfield G., Siller W.G., Wight P.A., and Moore K.J. X-chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci U S A 81 (1984) 1189-1192
7. Chandrasekar N., Sanjeeva M., Lakka S.S., Dinh D.H., Olivero W.C., Gujrati M., and Rao J.S. Glial cell-induced endothelial morphogenesis is inhibited by interfering with extracellular signal-regulated kinase signalling. Clin Cancer Res 9 (2003) 2342-2349
8. Croll S.D., Ransohoff R.M., Cai N., Zhang Q., Martin F.J., Wei T., Kasselman L.J., Kintner J., Murphy A.J., Yancoupoulos G.D., and Wiegand S.J. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp Neurol 187 (2004) 388-402
9. Crosbie R.H., Lebakken C.S., Holt K.H., Venzke D.P., Straub V., Lee J.C., Grady R.M., Chamberlain J.S., Sanes J.R., and Campbell K.P. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145 (1997) 153-165
10. Fischer S., Wobben M., Marti H.H., and Schaper W. Hypoxia-induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res 63 (2002) 70-80
11. Frigeri A., Nicchia G.P., Nico B., Quondamatteo F., Herken R., Roncali L., and Svelto M. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx-mice. FASEB J 15 (2001) 90-98
12. Gardner T.W. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. Trans Am Ophthalmol Sci 93 (1995) 583-621
13. Gijbels K., Masure S., Carton H., and Opdenakker G. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J Neuroimmunol 41 (1992) 29-34
14. Gottschall P.E., and Deb S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation 3 (1996) 69-75
15. Ibraghimov-Beskrovnaya O., Errasti J.M., Leveille C.J., Slaughter C.A., Sernett S.W., and Campbell K.P. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355 (1992) 696-702
16. Kherif S., Lafuma C., Dehaupas M., Lachkar S., Fournier J.G., Verdière-Sahuque M., Fardeau Kherif S., Lafuma C., Dehaupas M., and Alameddine H.S. Expression of matrix metalloproteinases 2 and 9 in regenerating skeletal muscle. a study in experimentally injured and mdx muscles. Dev Biol 205 (1999) 158-170
17. Kieseier B.C., Schneider C., Clements J.M., Gearing A.J., Gold R., Toyka K.V., and Hartung H.P. Expression of specific matrix metalloproteinases in inflammatory myopathies. Brain 124 (2001) 341-351
18. Kim S.K. Tight junctions, membrane associated guanylate kinases and cell signaling. Curr Opin Cell Biol 7 (1995) 641-649
19. Krause D., Mischek U., Galla H.J., and Dermietzel R. Correlation of zonula occludens ZO-1 antigen expression and transendothelial resistance in porcine and rat cultured endothelial cells. Neurosci Lett 128 (1991) 301-304
20. Leib S.L., Clements J., Lindberg R.L.P., Heimgartner C., Loeffer J.M., Pfister L.A., Täuber M.G., and Leppert D. Inhibition of matrix metalloproteinases and tumor necrosis factor-α converting enzymes as adjuvant therapy in pneumococcal meningitis. Brain 124 (2001) 1734-1742
21. Lorenzl S., Albers D.S., LeWitt P.A., Chirichigno J.W., Hilgenberg S.L., Cudkowicz M.E., and Beal M.F. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative disease. J Neurol Sci 207 (2003) 71-76
22. Markwell M.A., Haas S.M., Bieber L.L., and Tolbert N.E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87 (1978) 206-210
23. Massova I., Kotra L.P., Fridman R., and Mobashery S. Matrix metalloproteinases. structures, evolution and diversification. FASEB J 12 (1998) 1075-1095
24. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., and Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system. a regulatory mechanism with cell-bound reactants. EMBO J 16 (1997) 2319-2332
25. Mehler M.F. Brain dystrophin, neurogenetics and mental retardation. Brain Res Rev 32 (2000) 277-307
26. Millauer B., Wizigmann-Voos S., Schnurch J., Martinez R., Moller N.P.H., Risau W., and Ullrich A. High affinity VEGF binding and development expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72 (1993) 835-846
27. Muntoni F., Mateddu A., and Serra A. Passive avoidance behaviour deficit in mdx mouse. Neuromuscul Disord 1 (1991) 121-123
28. Nico B., Corsi P., Vacca A., Roncali L., and Ribatti D. Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 expression in mdx mouse brain. Brain Res 953 (2002) 12-16
29. Nico B., Frigeri A., Nicchia G.P., Corsi P., Ribatti D., Quondamatteo F., Herken R., Girolamo F., Marzullo A., Svelto M., and Roncali L. Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia 42 (2003) 235-251
30. Nico B., Nicchia G.P., Frigeri A., Corsi P., Mangieri D., Ribatti D., Svelto M., and Roncali L. Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience 125 (2004) 921-935
31. Ogunshola O.O., Stewart W.B., Mihalcik V., Solli T., Madri J.A., and Ment L.R. Neuronal VEGF expression correlates with angiogenesis in postnatal developing rat brain. Dev Brain Res 119 (2000) 139-153
32. Ozawa E., Noguchi S., Mizuno Y., Hagiwara Y., and Yoshida M. From dystrophinopathy to sarcoglycanopathy. evolution of a concept of muscular dystrophy. Muscle Nerve 21 (1998) 421-438
33. Peters M.F., Adams M.E., and Froehner S.C. Differential association of syntrophin pairs with the dystrophin complex. J Cell Biol 138 (1997) 81-93
34. Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., and Barone F.C. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats. inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29 (1998) 1020-1030
35. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
36. Rosenberg G.A., Cunningham L.A., Wallace J., Alexander S., Estrada E.Y., Grossetete M., Razhagi A., Miller K., and Gearing A. Immunohistochemistry of matrix metalloproteinase in reperfusion injury to rat brain. activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures. Brain Res 893 (2001) 104-112
37. Rosenberg G.A. Matrix metalloproteinase in neuroinflammation. Glia 39 (2002) 279-291
38. Sato H., and Seiki M. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8 (1993) 395-405
39. Shravan K.C., Sawaya R., Aggarwal B.B., Majumder S., Giri D.K., Kyritsis A.P., Gokaslan Z.L., and Rao J.S. Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J Biol Chem 273 (1998) 13545-13551
40. Sohar I., Laszlo A., Gaal K., and Mechler F. Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes. Biol Chem Hoppe Seyler 369 (1988) 277-279
41. St-Pierre Y., Couillard J., and Van Themsche C. Regulation of MMP-9 gene expression for the development of novel molecular targets against cancer and inflammatory diseases. Expert Opin Ther Targets 8 (2004) 473-489
42. Trojano M., Avolio C., Liuzzi G.M., Ruggieri M., Defazio G., Liguori M., Santacroce M.P., Paolicelli D., Giuliani F., Riccio P., and Livrea P. Changes of serum sICAM-1 and MMP9 induced by rINFβ-1b treatment in relapsing-remitting MS. Neurobiology 53 (1999) 1402-1408
43. Tomasek J.J., Halliday N.L., Updike D.L., Ahern-Moore J.S., Vu T.K., Liu R.W., and Howard E.W. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J Biol Chem 272 (1997) 7482-7487
44. Ueda H., Baba T., Terada N., Kato Y., Fuji Y., Takayama I., Mei X., and Ohno S. Immunolocalization of dystrobrevin in the astrocytic endfeet and endothelial cells in the rat cerebellum. Neurosci Lett 283 (2000) 121-124
45. Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., Ria R., Albini A., Bussolino F., and Dammacco F. Bone marrow neovascularization, plasma cella angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 93 (1999) 3064-3073
46. Vacca A., Ribatti D., Ria R., Pellegrino A., Bruno M., Merchionne F., and Dammacco F. Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression. Dev Immunol 7 (2000) 77-88
47. Weir A.P., Burton E.A., Harrod G., and Davies K.E. A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle. J Biol Chem 277 (2002) 45285-45290
48. Yong V.W., Krekoski C.A., Forsyth P.A., Bell R., and Edwards D.R. Matrix metalloproteinases and diseases of the CNS. Trends Neurosci 2 (1998) 75-80
49. Yong V.W., Power C., Forsyth P.A., and Edwards D.R. Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2 (2001) 502-511